Mesoblast Limited
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -17.0% | -15.9% | -13.3% |
| FY2022 | -18.4% | -15.5% | -13.8% |
| FY2023 | -16.3% | -13.5% | -12.2% |
| FY2024 | -18.3% | -15.1% | -13.1% |
| FY2025 | -17.1% | -15.4% | -13.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -17.0% | -15.9% | -13.3% |
| FY2022 | -18.4% | -15.5% | -13.8% |
| FY2023 | -16.3% | -13.5% | -12.2% |
| FY2024 | -18.3% | -15.1% | -13.1% |
| FY2025 | -17.1% | -15.4% | -13.0% |